Figma's blockbuster debut has broken years of IPO drought, potentially opening the floodgates for other high-growth tech companies to go public.
Venture-backed unicorns may now accelerate their public offerings, creating fresh investment opportunities in previously private companies.
The strong market reception signals a shift in sentiment towards tech equities, potentially benefiting established players in this space.
Figma's successful IPO has broken a multi-year drought in major tech listings, potentially signalling a turning point for the technology sector. This renewed investor confidence could create a more favourable environment for other venture-backed unicorns to go public, particularly in the software-as-a-service space.
This collection focuses on high-growth tech companies that could benefit from the revived IPO market sentiment. It includes a mix of recently public firms and established software players that reflect this broader shift in investor appetite for technology equities.
These stocks were handpicked by professional analysts to capture potential upside from renewed market activity in the tech sector. They represent companies positioned to benefit from the reopening of the technology IPO market and subsequent value creation opportunities.
Figma's blockbuster IPO has shattered a multi-year drought in major tech listings, signaling renewed investor appetite for high-growth software companies. This event may trigger a wave of public offerings from other venture-backed "unicorns," creating opportunities across the tech ecosystem.
Aggregated market capitalisation breakdown for the basket 'Riding The New Tech IPO Wave'.
TEAM: $44.41B
ADBE: $149.67B
SNOW: $83.86B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+8
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 37.01% over the next year.
13 of 18 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+37.01%
